Simulations Plus Extends Agreement with NIEHS

Simulations Plus extends collaboration with major toxicology research agency, NIEHS

Overview

Simulations Plus, Inc., a leading provider of modelling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, announced an extension to the formal agreement with the Translational Toxicology Division at the National Institute of Environmental Health Sciences (NIEHS) to support the rapid safety assessment of chemicals in animals and humans.

Words Form Scientist at NIEHS

At NIEHS, we seek to expand scientific knowledge and approach methods linking the environment and human health. The Division of Translational Toxicology (DTT) at NIEHS provides health effects research to federal, state and local health agencies to identify emerging public health issues and support the conduct of formal risk assessments and decision-making,” said Stephen Ferguson, Ph.D., scientific lead for the NIEHS project. “The agreement with Simulations Plus provides computational tools that support investigations of environmental chemicals and their potential health effects.

Computational Models for Toxicology Data

Computational model predictions from ADMET Predictor and GastroPlus enable in vitro to in vivo extrapolation (IVIVE) that relates biologically-active exposure levels to environmental exposure scenarios. This enables more accurate estimates of chemical safety margins (Sipes et al. 2017. Environ Sci Technol, Sep 19;51(18):10786-10796. doi: 10.1021/acs.est.7b00650) and a framework for integration of various types of toxicology data (e.g., mechanistic data, in vivo & in vitro toxicology studies) for decision-making (e.g., risk assessments, safer product formulation).

“Importantly, these tools are being investigated for their potential to address a critical gap in toxicology research for understanding and modelling human bioactivation of environmental chemicals through xenobiotic metabolism,” Ferguson added.

Simulations Plus on Their Software

It’s critical to understand how chemicals may react in the body, and that can vary depending on whether they are inhaled or absorbed through the skin, whether the person was an adult or child, and if there are other health conditions present,” said Michael Lawless , Sr. Principal Scientist in the Cheminformatics Solutions team at Simulations Plus. As in vivo testing becomes more and more limited, the application of our software to support new approach methodologies (NAMs) to predict those outcomes becomes more crucial, and we are proud to be working with DTT/NIEHS to support their environmental health and safety research activities.

GastroPlus Software

• GastroPlus is a mechanistically based modeling and simulation software that simulates intravenous, oral, intraoral (oral cavity), pulmonary (respiratory), ocular, dermal (topical and subcutaneous), intramuscular, and intraarticular routes of administration, as well as biopharmaceutics, pharmacokinetics, and drug-drug interactions in humans and animals. 

• It is the leading physiologically based pharmacokinetic/physiologically based biopharmaceutics modelling (PBPK/PBBM) platform, built and refined over 25 years on the most up-to-date scientific research.

Machine Learning: ADMET Predictor

ADMET Predictor is a machine learning (ML) platform that predicts the absorption, distribution, metabolism, excretion, and toxicity (ADMET) of new molecules. It incorporates more premium and extensively curated data from pharmaceutical and agrochemical partners than any other cheminformatics platform, which provides enhanced predictive accuracy and wider applicability of its models.

About Simulations Plus

Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!